JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Identification and analysis of significant genes in nonalcoholic steatohepatitis-hepatocellular carcinoma transformation: Bioinformatics analysis and machine learning approach

  • 0Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Molecular Immunology +

|

August 14, 2024

|

August 14, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Researchers identified five key genes (ME1, TP53I3, SOCS2, GADD45G, CYP7A1) driving nonalcoholic steatohepatitis (NASH) to liver cancer (HCC) progression. TP53I3 and SOCS2 show particular promise for diagnosing and treating NASH-related HCC.

Area Of Science

  • Hepatology and Oncology
  • Molecular Biology
  • Genetics

Background

  • Nonalcoholic steatohepatitis (NASH) is a growing cause of hepatocellular carcinoma (HCC).
  • Understanding the molecular mechanisms of NASH progression to HCC is crucial for early detection and effective treatment strategies.

Purpose Of The Study

  • To identify prognostic genes associated with the transformation from NASH to HCC.
  • To develop a diagnostic model for NASH prediction.
  • To investigate the role of specific genes and cell types in NASH-HCC progression.

Main Methods

  • Bioinformatic analysis of gene expression data.
  • Algorithm selection to identify significant prognostic genes.
  • External dataset validation and in vitro experiments using NASH and HCC cell lines.
  • Immune infiltration and single-cell RNA sequencing analyses.

Main Results

  • Five significant prognostic genes (ME1, TP53I3, SOCS2, GADD45G, CYP7A1) were identified for NASH-HCC transformation.
  • A diagnostic model for NASH prediction achieved high accuracy (AUC=0.988).
  • TP53I3 and SOCS2 were validated as potential critical genes in NASH-HCC progression.
  • Single-cell analysis revealed the promoting role of specific hepatocytes in NASH-HCC transformation.

Conclusions

  • The study identified and validated five key genes involved in NASH-HCC transformation using multi-omics approaches.
  • TP53I3 and SOCS2 are highlighted as potential critical genes for NASH-HCC progression.
  • The findings offer novel insights into the diagnosis and treatment of NASH-related HCC.

Keywords: